QL-1200186

DESCRIPTION

QL-1200186 is an orally active, selective TYK2 inhibitor that, upon dose-dependent oral administration, suppresses interferon-γ (IFNγ) production following interleukin-12 (IL-12) stimulation and markedly improves skin lesions in a psoriatic mouse model [1].

DETAILS

Cas: 2848664-42-4
Purity: 98%
Smiles: O=C(NC)C1=CN=C2C=C1NC3=CC(=CC(C4=NN(C=C4)C)=C3OC)CCOCC5=NC(=CC=C5)N2
Category: Compound
Molecular Weight: 485.54
Molecular Formula: C26H27N7O3

Lead Time: 4 - 5 weeks